Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

The Effects of MeOH Extract of Hopea chinensis (Merr.) Hand.-Mazz. on the Metabolism of Amyloid Precursor Protein in Neuroblastoma Cells

Hopea chinensis (Merr.) Hand.-Mazz. 메탄올 추출물이 신경세포에서 아밀로이드 전구 단백질 대사에 미치는 영향

  • Received : 2018.06.23
  • Accepted : 2018.06.28
  • Published : 2018.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Many plant derived phytochemicals have been considered as the main therapeutic strategy against Alzheimer's disease (AD). AD is a progressive neurodegenerative disorder, and the most predominant cause of dementia in the elderly. Cholinergic deficit, senile plaque/${\beta}$-amyloid ($A{\beta}$) peptide deposition and oxidative stress have been identified as three main pathogenic pathways which contribute to the progression of AD. We screened many different plant species for their effective use in both modern and traditional system of medicines. In this study, we tested that MeOH extract of the stem bark of Hopea chinensis (Merr.) Hand.-Mazz. (HCM) affects on the processing of Amyloid precursor portein (APP) from the APPswe over-expressing Neuro2a cell line. We showed that HCM reduced the secretion level of $A{\beta}42$ and $A{\beta}40$ in a dose dependent manner. We found that HCM increased over 1.5 folds of the secretion level of $sAPP{\alpha}$, a metabolite of ${\alpha}$-secretase. Furthermore, we found that HCM inhibited acetylcholinesterase activity in vitro. We suggest that the stem bark of Hopea chinensis may be a useful source to develop a therapeutics for AD.

Keywords

References

  1. 통계청 자료(http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B35001)
  2. Morris, J. C. (1996) Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165: 41-50.
  3. Selkoe, D. J. (1998) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8: 447-453. https://doi.org/10.1016/S0962-8924(98)01363-4
  4. Strittmatter, W. J., Weisgraber, K. H. Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102. https://doi.org/10.1073/pnas.90.17.8098
  5. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A .D., Haines, J. L. and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. https://doi.org/10.1126/science.8346443
  6. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G. and Citron, M. (1999) ${\beta}$-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741. https://doi.org/10.1126/science.286.5440.735
  7. Selkoe, D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31. https://doi.org/10.1038/19866
  8. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L. and Wong, P. C. (2001) BACE1 is the major ${\beta}$-secretase for generation of $A{\beta}$ peptides by neurons. Nature Neurosci. 4: 233-234. https://doi.org/10.1038/85064
  9. Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C. S., Pang, Y., Youdim, M. B. and Han, Y. (2009) Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Eur. J. Pharmacol. 623: 14-21. https://doi.org/10.1016/j.ejphar.2009.09.013
  10. Sugimoto, H. (2001) Donepezil hydrochloride. a treatment drug for Alzheimer's disease. Chem. Rec. 1: 63-73. https://doi.org/10.1002/1528-0691(2001)1:1<63::AID-TCR9>3.0.CO;2-J
  11. Zarotsky, V., Sramek, J. J. and Cutler, N. R. (2003) Galantamine hydrobromide. an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60: 446-452.
  12. Jann, M. W. (2000) Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20: 1-12. https://doi.org/10.1592/phco.20.1.1.34664
  13. Ge, H. M., Zhu, C. H., Shi, D. H., Zhang, L. D., Xie, D. Q., Yang, J., Ng, S. W. and Tan RX. (2008) Hoeahainol A: an acetylcholinesterase inhibitor from Hopea hainanensis. Chem. Eur. J. 14: 376-381. https://doi.org/10.1002/chem.200700960
  14. 1. Yan, T., Wang, T., Wei, W., Jiang, N., Qin, Y. H., Tan, R. X. and Ge, H. M. (2012) Polyphenolic acetylcholinesterase inhibitors from Hopea chinensis. Planta Med. 78: 1015-1019. https://doi.org/10.1055/s-0031-1298623
  15. Ge, H. M., Yang, W. H., Shen, Y., Jiang, N., Guo, Z.K., Luo. Q., Xu, Q., Ma, J. and Tan, R. X. (2010) Immunosuppressive resveratrol aneuploids from Hopea chinensis. Chemistry. 16: 6338-6345. https://doi.org/10.1002/chem.201000230
  16. Wang, R., Sweeney, D., Gandy, S. E. and Sissodia, S. S. (1996) The profile of soluble amyloid ${\beta}$ protein in cultured cell media. J. Biol. Chem. 271: 31894-31902. https://doi.org/10.1074/jbc.271.50.31894
  17. Harun A., Muhammad J. J. R., Lim S. M, Bakar A. M. A., Cole A. L. J. and Ramasamy K. (2011) BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plants. BMC Complement Altern. Med. 11: 79. https://doi.org/10.1186/1472-6882-11-79
  18. Leem, J. Y., Saura, C. A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L. T., Veselits, M. L., Tomita, T., Gasparini, L., Iwatsubo, T., Xu, H., Green, W. N., Koo, E. H. and Thinakaran, G. (2002) A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11: 64-82. https://doi.org/10.1006/nbdi.2002.0546
  19. Tung, J. S., Davis, D. L., Anderson, J. P., Walker, D. E., Mamo, S., Jewett, N., Hom, R. K., Sinha, S. and Thorsett, E. D., John, V. (2002) Design of substrate-based inhibitors of human beta-secretase. J. Med. Chem. 45: 259-262. https://doi.org/10.1021/jm0155695
  20. Iqbal, K., Sisodia, S. S. and Winblad, B. (2001) Alzheimer's disease. Advances in etiology, pathogenesis and therapeutics. John Wiley & Sons, Ltd.
  21. Li, N., Zhou, L., Li, W., Liu, Y., Wang, J. and He, P. (2015) Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: A metabolomics study. J. Chromatogr. B Analyt.. Technol. Biomed. Life Sci. 985: 54-61. https://doi.org/10.1016/j.jchromb.2015.01.016
  22. Uchida N, Takasaki K, Sakata Y, Nogami A, Oishi H, Watanabe T, Shindo T, Egashira N, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M, Nishimura R, Iwasaki K. (2013) Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease. Phytother. Res. 27: 966-972. https://doi.org/10.1002/ptr.4818
  23. Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. (2002) PEN-2 is an integral component of the ${\gamma}$-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277: 39062-39061. https://doi.org/10.1074/jbc.C200469200
  24. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. https://doi.org/10.1126/science.1072994
  25. Sambamurti, K., Hardy, J., Refolo L. M. and Lahiri, D. K. (2002) Targeting APP metabolism for the treatment of Alzheimer's disease. Drug Dev. Res. 56: 211-227. https://doi.org/10.1002/ddr.10077
  26. Skovronsky, D. M., Moore, D. B., Milla, M. E., Doms, R. W. and Lee, V. M. (2000) Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J. Biol. Chem. 275: 2568-2575. https://doi.org/10.1074/jbc.275.4.2568
  27. Nunan, J. and Small, D. H. (2000) Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483: 6-10. https://doi.org/10.1016/S0014-5793(00)02076-7
  28. Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P. and Selkoe. D. J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3: 67-72. https://doi.org/10.1038/nm0197-67
  29. Kuo, Y. M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J. and Roher, A. E. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271: 4077-4081. https://doi.org/10.1074/jbc.271.8.4077
  30. Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T. and Iwatsubo, T. (2003) Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. J. Biol. Chem. 278: 18664-18670. https://doi.org/10.1074/jbc.M301619200
  31. Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, MP. and Tan, J. (2012) Soluble amyloid precursor protein-${\alpha}$ modulates ${\beta}$-secretase activity and amyloid-${\beta}$ generation. Nat. Commun. 3: 777. https://doi.org/10.1038/ncomms1781